載入...
A Review of the Evidence for Using Bedaquiline (TMC207) to Treat Multi-Drug Resistant Tuberculosis
Existing therapies for multi-drug resistant tuberculosis (MDR-TB) have substantial limitations, in terms of their effectiveness, side-effect profile, and complexity of administration. Bedaquiline is a novel diarylquinoline antibiotic that has recently been investigated as an adjunct to existing ther...
Na minha lista:
| Main Authors: | , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Springer Healthcare
2013
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4108107/ https://ncbi.nlm.nih.gov/pubmed/25134476 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40121-013-0009-3 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|